NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,972,544 | -43.2% | 206,688 | -24.9% | 0.00% | 0.0% |
| Q2 2023 | $6,993,525 | -5.2% | 275,119 | +34.9% | 0.00% | 0.0% |
| Q1 2023 | $7,374,058 | +313.8% | 203,985 | +353.3% | 0.00% | – |
| Q4 2022 | $1,782,000 | -66.2% | 45,000 | -60.2% | 0.00% | -100.0% |
| Q3 2022 | $5,269,000 | +97.4% | 113,070 | +85.7% | 0.00% | 0.0% |
| Q2 2022 | $2,669,000 | -58.5% | 60,900 | -31.5% | 0.00% | 0.0% |
| Q1 2022 | $6,430,000 | -37.3% | 88,900 | -29.8% | 0.00% | – |
| Q4 2021 | $10,262,000 | +40.7% | 126,572 | +101.9% | 0.00% | – |
| Q3 2021 | $7,295,000 | -35.9% | 62,682 | -8.7% | 0.00% | -100.0% |
| Q2 2021 | $11,377,000 | +105.8% | 68,624 | +73.2% | 0.00% | – |
| Q1 2021 | $5,527,000 | -75.0% | 39,628 | -69.0% | 0.00% | -100.0% |
| Q4 2020 | $22,144,000 | +25.1% | 127,930 | +0.7% | 0.00% | -33.3% |
| Q3 2020 | $17,696,000 | -22.2% | 127,034 | -33.3% | 0.00% | -50.0% |
| Q2 2020 | $22,754,000 | -20.7% | 190,458 | -33.6% | 0.01% | -25.0% |
| Q1 2020 | $28,683,000 | +19.5% | 286,883 | +40.5% | 0.01% | +33.3% |
| Q4 2019 | $24,002,000 | +20.7% | 204,200 | -11.7% | 0.01% | -14.3% |
| Q3 2019 | $19,885,000 | -54.2% | 231,295 | -65.4% | 0.01% | +40.0% |
| Q2 2019 | $43,396,000 | +225.6% | 669,345 | +214.0% | 0.01% | -16.7% |
| Q1 2019 | $13,328,000 | -47.4% | 213,200 | -67.3% | 0.01% | -40.0% |
| Q4 2018 | $25,337,000 | +206.8% | 651,516 | +349.7% | 0.01% | +233.3% |
| Q3 2018 | $8,258,000 | +42.7% | 144,866 | +100.0% | 0.00% | +50.0% |
| Q2 2018 | $5,785,000 | -49.0% | 72,445 | -44.7% | 0.00% | -50.0% |
| Q1 2018 | $11,354,000 | +35.6% | 131,000 | +8.0% | 0.00% | +33.3% |
| Q4 2017 | $8,373,000 | -66.4% | 121,283 | -55.7% | 0.00% | -70.0% |
| Q3 2017 | $24,883,000 | +85.0% | 273,800 | +51.5% | 0.01% | +66.7% |
| Q2 2017 | $13,448,000 | +9.9% | 180,679 | +38.3% | 0.01% | 0.0% |
| Q1 2017 | $12,237,000 | -28.0% | 130,600 | -44.2% | 0.01% | -33.3% |
| Q4 2016 | $16,993,000 | +31.4% | 233,883 | +88.8% | 0.01% | +50.0% |
| Q3 2016 | $12,934,000 | -34.0% | 123,900 | -53.4% | 0.01% | -45.5% |
| Q2 2016 | $19,606,000 | +398.5% | 265,800 | +280.3% | 0.01% | +450.0% |
| Q1 2016 | $3,933,000 | -47.8% | 69,900 | -37.4% | 0.00% | -33.3% |
| Q4 2015 | $7,539,000 | +62.3% | 111,678 | +11.5% | 0.00% | +200.0% |
| Q3 2015 | $4,645,000 | +92.7% | 100,136 | +123.2% | 0.00% | – |
| Q2 2015 | $2,411,000 | +290.8% | 44,858 | +181.3% | 0.00% | – |
| Q4 2014 | $617,000 | – | 15,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |